ResearcherAmsterdam University Medical CentersNo recent work listed

Dario P. Anobile

ORCID-verified (high confidence, 0.95), identity_conf@1As of 8 November 2026

Matched on ORCID iD 0000-0002-5486-6438; OpenAlex author ID A5038060413. Sources: OpenAlex.

Their work

Papers: 1
Trials: 0
Grants: 0
Labs led: 0
Collaborators: 4

Papers, trials and grants by year

2022: 1 paper

Papers 1

New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4. Co-author DOI 10.3390/molecules27051682 ↗

Closest collaborators

The 4 strongest of 4 by collab_strength@1: shared papers, trials and grants, recent and small-team work weighing most.

Carmen Abate · 1 shared paper, 2022 · strength 0.16
- Paper New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4. DOI 10.3390/molecules27051682 ↗
Mauro Niso · 1 shared paper, 2022 · strength 0.16
- Paper New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4. DOI 10.3390/molecules27051682 ↗
Amir Avan · 1 shared paper, 2022 · strength 0.16
- Paper New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4. DOI 10.3390/molecules27051682 ↗
Elisa Giovannetti · 1 shared paper, 2022 · strength 0.16
- Paper New Pharmacological Strategies against Pancreatic Adenocarcinoma: The Multifunctional Thiosemicarbazone FA4. DOI 10.3390/molecules27051682 ↗

How to reach this person

A chain of introductions through people who have published, run trials or held grants together (warm_path@1: fewest links first, then the strongest). Built from public records only; no contact details are kept.